This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Prognosis for children diagnosed with Kawasaki disease (KD) is primarily based upon extent and severity of coronary artery involvement at diagnosis and at follow-up (1)

  • case-fatality rate in the United States and Japan is less than 0.2%, and the principal cause of death is myocardial infarction resulting from coronary artery occlusion
  • AHA 2017 guidelines for diagnosis, treatment, and management of KD provide a detailed risk classification scheme
    • classification system is divided into five risk categories utilizing both Z scores and absolute luminal dimensions
    • lowest risk level is 1, indicating no involvement of the coronary arteries (Z score< 2)
      • these patients are screened with echocardiogram during the acute illness, and then again at 6-8 weeks after onset
        • appear to have a similar risk profile to patients without a diagnosis of KD

Reference:

  1. Rife E, Gedalia A. Kawasaki Disease: an Update. Curr Rheumatol Rep. 2020;22(10):75. Published 2020 Sep 13. doi:10.1007/s11926-020-00941-4

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.